Jpmorgan Chase & CO Editas Medicine, Inc. Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 799,198 shares of EDIT stock, worth $2.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

799,198

Previous 981,521 18.58%

Holding current value

$2.3 Million

Previous $7.28 Million 48.75%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$4.67 - $7.28 $851,448 - $1.33 Million	-182,323 Reduced 18.58%	799,198 $3.73 Million
Q1 2024 May 10, 2024	SELL	$7.03 - $11.07 $488,486 - $769,210	-69,486 Reduced 6.61%	981,521 $7.28 Million
Q4 2023 Feb 12, 2024	SELL	$6.25 - $11.11 $58,025 - $103,145	-9,284 Reduced 0.88%	1,051,007 $10.6 Million
Q3 2023 Nov 14, 2023	SELL	$6.92 - $9.31 $444,360 - $597,832	-64,214 Reduced 5.71%	1,060,291 $8.27 Million
Q2 2023 Aug 11, 2023	SELL	$6.36 - $11.47 $53,716 - $96,875	-8,446 Reduced 0.75%	1,124,505 $9.25 Million
Q1 2023 May 18, 2023	BUY	$7.03 - $11.53 $608,798 - $998,498	86,600 Added 8.28%	1,132,951 $8.21 Million
Q1 2023 May 11, 2023	SELL	$7.03 - $11.53 $958,210 - $1.57 Million	-136,303 Reduced 11.53%	1,046,351 $7.59 Million
Q4 2022 Feb 13, 2023	BUY	$8.32 - $13.21 $160,808 - $255,322	19,328 Added 1.66%	1,182,654 $10.5 Million
Q3 2022 Nov 14, 2022	SELL	$12.16 - $19.42 $453,264 - $723,880	-37,275 Reduced 3.1%	1,163,326 $14.2 Million
Q2 2022 Aug 11, 2022	SELL	$9.99 - $21.35 $559,040 - $1.19 Million	-55,960 Reduced 4.45%	1,200,601 $14.2 Million
Q1 2022 May 11, 2022	SELL	$14.08 - $27.63 $2.92 Million - $5.73 Million	-207,502 Reduced 14.17%	1,256,561 $23.9 Million
Q4 2021 Feb 10, 2022	BUY	$26.55 - $40.57 $8.93 Million - $13.6 Million	336,305 Added 29.82%	1,464,063 $38.9 Million
Q3 2021 Nov 12, 2021	BUY	$39.27 - $72.94 $44.3 Million - $82.3 Million	1,127,758 New	1,127,758 $46.3 Million

Others Institutions Holding EDIT

# of Institutions

244

Shares Held

58.9M

Call Options Held

494K

Put Options Held

417K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $198M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Editas Medicine, Inc. Transaction History